Elite Pharmaceuticals Inc (ELTP)

[IB_]

Could this be Nasrats plan for 250 million+ shares,"Elite's CEO has no intention of taking steps to increase the share price or reach the Nasdaq. The intellectual patents for ART are currently worthless because no products using the technology have been approved and marketed. The CEO and other board members who are paid and bonus compensated in shares are very content with a .05 share price. This allows them to receive far more shares as payment then if the price was significantly higher. They are content fleecing the remaining 500m shares from the company while marketing some generic products that do add some overall value to the company. They will then sell the business to a larger company for maybe
20 or .25 a share giving them 5x their current salary and compensation that is paid in shares. Of course their final cost average will dictate their profit margin. They are just fleecing it dry without consideration to current shareholders. Now if shareholder current cost average is under .20 then the shareholder will make a little money. Not the 75 million dollars the CEO will cash out of course. They will probably try and bring one more generic or two online before the sale of the business. I'd say 12 to 16 months at most. CEO and other executives walk away with huge compensations. Lower employees keep their jobs with the new company and the majority of shareholders look at their empty bag. This is very common with OTC companies in my opinion."

Hummmm,

IB_